CORRECTED-UPDATE 2-VBL to stop developing drug for psoriasis, ulcerative colitis

Feb 17 (Reuters) - Israel's VBL Therapeutics said it would stop developing its experimental inflammatory drug to fight psoriasis and ulcerative colitis, leading to half its market value being wiped...